CoChat

DNMT3A mutations occur early or late in patients with myeloproliferative neoplasms and mutation order influences phenotype

Open access
Nangalia, J., Nice, F. L., Wedge, D. C., Godfrey, A. L., Grinfeld, J., Thakker, C., Massie, C. E., Baxter, J., Sewell, D., Silber, Y., Campbell, P. J., Green, A. R. · 2015 · Haematologica
Cited by 133

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

DNMT3A mutations occur early or late in patients with myeloproliferative neoplasms and mutation order influences phenotype Somatic mutations in JAK2, CALR and MPL are found in the majority of myeloproliferative neoplasms (MPN) but many patients also harbor somatic mutations in epigenetic regulators of DNA methylation (TET2, DNMT3A and IDH1/2) or chromatin structure (ASXL1 and EZH2).In MPN patients, mutations in TET2, ASXL1 and EZH2 occur either prior to or following the acquisition of JAK2 V617F 1 and, recently, the order of mutation acquisition for JAK2 V617F and TET2 has been shown to influence hematopoietic stem/progenitor cell biology and clinical presentation.2 DNMT3A is the next most frequently mutated gene in MPN after TET2, affecting 7-10% of patients.[3][4][5] However in contrast to other mutations, DNMT3A mutations (DNMT3A mut ) have only been reported early in myeloid disease: prior to acquisition of JAK2 V617F or in a separate clone in MPN; 1,6 prior to NPM1 or FLT3 mutations in de novo acute myeloid leukemia; 7 and prior to transformation of MPN or myelodysplasia into acute myeloid leukemia.8 In this study we used clonal analysis of hematopoietic colonies from DNMT3A mut MPN patients to investigate timing of mutation acquisition, subclonal evolution, and the influence of mutation order.Thirteen DNMT3A mut MPN patients were identified in whom viable material was available for clonal analysis (Online Supplementary Table S1): nine JAK2 V617F -mutated and two MPL-mutated patients identified by exome-sequencing, one JAK2 exon12 -mutated patient identified by wholegenome sequencing, and one CALR-mutated patient identified by targeted gene screening.MPN diagnoses conformed to British Committee for Standards in Haematology.All samples were obtained following written informed consent and ethical approval.Peripheral blood mononuclear cells were cultured to obtain burstforming units-erythroid (BFU-E) as described previously, 2 and 2991 individual colonies (average of 230 colonies/patient) were genotyped by Sanger sequencing for mutations in DNMT3A, JAK2, CALR and MPL.DNMT3A mut occurred prior to acquisition of JAK2 V617F in four patients ('DNMT3A-first' patients, Figure 1A) as evidenced by single-mutant colonies harboring DNMT3A mut only and double-mutant colonies with DNMT3A mut and JAK2 V617F.Single-mutant colonies represented a substantial proportion of BFU-E (mean 58%, range 27%-86%), consistent with mutant allele fractions from granulocyte whole-exome sequencing, and indicating the presence of significant 'pre-JAK2' multi-lineage clonal hematopoiesis in these patients.These results accord with observations of clonal hematopoiesis in patients with essential thrombocythemia despite low allele burdens of JAK2 V617F , 9 and with reports of DNMT3A mut -associated clonal hematopoiesis in normal individuals.10,11 In three patients, DNMT3A mut and JAK2 V617F colonies were mutually exclusive ('biclonal' patients, Figure 1B).In such patients, the two mutations arose either in separate cells downstream of a shared ancestral clone or in clonally unrelated cells.DNMT3A mut and JAK2 V617F clones did not share any of the additional mutations identified by exome sequencing in the three biclonal patients (Figure 2 patients #25, #81, #27).Moreover, in one of the two female patients, DNMT3A mut and JAK2 V617F clones harbored different active X-chromosomes (Online Supplementary Figure S1).These data demonstrate that DNMT3A mut and JAK2 V617F clones in the same patient can represent clonally-unrelated expansions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3324/haematol.2015.129510

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 133

Metadata

Authors
Nangalia, J., Nice, F. L., Wedge, D. C., Godfrey, A. L., Grinfeld, J., Thakker, C., Massie, C. E., Baxter, J., Sewell, D., Silber, Y., Campbell, P. J., & Green, A. R.
Venue
Haematologica
Published
2015-08-06
Volume
100
Issue
11
Pages
e438-e442
ISSN
  • 0390-6078 (ISSN-L)
  • 1592-8721
OpenAlex
W2175028143
Cited by
133
References
7
FWCI
5.05
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: DNMT3A mutations occur early or late in patients with myeloproliferative neoplasms and mutation order influences phenotype. https://app.cochat.ai/papers/10.3324/haematol.2015.129510
The paper
Nangalia, J., Nice, F. L., Wedge, D. C., Godfrey, A. L., Grinfeld, J., Thakker, C., Massie, C. E., Baxter, J., Sewell, D., Silber, Y., Campbell, P. J., & Green, A. R. (2015). DNMT3A mutations occur early or late in patients with myeloproliferative neoplasms and mutation order influences phenotype. Haematologica. https://doi.org/10.3324/haematol.2015.129510

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.